Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine

This publication has 21 references indexed in Scilit:

• Antibodies to Haemophilus influenzae Serotype b in The Netherlands a Few Years after the Introduction of Routine Vaccination
  Clinical Infectious Diseases, 2001
• SERUM ANTIBODIES IN SIX-YEAR-OLD CHILDREN VACCINATED IN INFANCY WITH A HAEMOPHILUS INFLUENZAE TYPE b-TETANUS TOXOID CONJUGATE VACCINE
  The Pediatric Infectious Disease Journal, 1996
• Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era
  Published by American Medical Association (AMA) ,1993
• High Antibody Responses to Booster Doses of Either Haemophilus influenzae CapsularPolysaccharide or Conjugate Vaccine after Primary Immunization with Conjugate Vaccines
  The Journal of Infectious Diseases, 1992
• IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN
  The Lancet, 1986
• ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE
  The Lancet, 1985
• The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b
  The Journal of Infectious Diseases, 1983
• Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland
  The Journal of Infectious Diseases, 1977
• Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria
  Journal of Allergy and Clinical Immunology, 1975
• BACTERIAL ANTIGENS CROSS-REACTIVE WITH THE CAPSULAR POLYSACCHARIDE OF HÆMOPHILUS INFLUENZÆ TYPE b
  The Lancet, 1971